The underdiagnosis and undertreatment of psoriatic arthritis represents a significant healthcare gap that increases the potential for severe disease burden, including decreased physical function and quality of life. This interactive case-based activity will examine screening, diagnosis and evidence-based treatment options.

1. Diagnose psoriatic arthritis using clinical examination, questionnaires, and laboratory and imaging studies;
2. Develop a management plan for newly diagnosed patients with psoriatic arthritis based on disease severity.

There are no fees for participating in and receiving CME credit for this online activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of .50 AMA PRA Category 1 Credit^TM. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Faculty Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Cincinnati College of Medicine has a conflict of interest policy that requires, all faculty, planning committee members, and other individuals who are in a position to control content, to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosure will be made at the time of activity.

Medical Director / Program Planners

MCM Education

Kathleen Hines, Vice President, Editorial Services
Lillian McVey, Writer/Editor

University of Cincinnati Continuing Medical Education Office

Heather Muskopf, Program Manager
Susan P. Tyler, MEd, CMP, CHCP, Director

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati College of Medicine nor MCM Education, recommends the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati College of Medicine or MCM Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement
The opinions expressed during this educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees professional development.

Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

To view faculty disclosures, visit the faculty tab.

Joseph F. Merola, MD, MMSc
Associate Professor, Harvard Medical School; Director, Clinical Unit for Research Innovation and Trials; Director, Center for Skin and Related Musculoskeletal Disease, Dept. of Dermatology and Dept. of Medicine, Div. of Rheumatology; Associate Program Director, Combined Medicine-Dermatology Residency Program
Brigham and Women's Hospital
Boston, MA

Eric Ruderman, MD
Professor of Medicine; Associate Chief, Clinical Affairs
Northwest University, Feinberg School of Medicine
Chicago, IL

This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.